Article successfully added.

CyFlow™ CD90.2 PE

CyFlow™ CD90.2 PE
Antibody: Yes
Antigen: CD90.2
Application: Flow cytometry
Clonality: monoclonal
Clone: 1aG4/C5
Emission Maximum: 576 nm
Excitation Maximum: 496 nm, 565 nm
Field of Interest: Immunophenotyping, MHC
Format/Fluorochrome: PE
Isotype: IgG3
Laser: Blue , Green, Yellow
Regulatory Status: RUO
Source Species: Mouse
Target Species: Mouse
Product number: CN347786

For Research Use Only

$255.00 USD*

Price excludes any applicable taxes plus shipping costs

Description Documentation TDS & SDS
Description
Concentration Unit mg/mL Concentration 0,1 Quantity 0.1 mg Volume 1.0 mL... more
Close menu
CyFlow™ CD90.2 PE
Concentration Unitmg/mL
Concentration0,1
Quantity0.1 mg
Volume1.0 mL
ImmunogenThymocytes from C3H/Di mice (Thy-1.2 positive)
Background InformationCD90 (Thy-1) is an 18-35 kDa GPI-anchored plasma membrane glycoprotein expressed in many cell types, such as in hematopoietic cells and neurons, connective tissues, various fibroblast and stromal cell lines, tumor endothelial cell lines and other. In the mouse, CD90 is expressed mainly on thymocytes and peripheral T lymphocytes. It is involved in T cell activation, cellular adhesion, proliferation and migration, neurite outgrowth, wound healing, apoptosis, and fibrosis. CD90 participates in multiple signaling cascades and its effects are tissue- and cell type-specific. It often functions as an important regulator of cell-cell and cell-matrix interactions.
UsageThe reagent is designed for Flow Cytometry analysis. Working concentrations should be determined by the investigator.
Storage BufferThe reagent is provided in stabilizing phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.
Specific References

| Draber P, Zikan J, Vogtiskova M: Establishment and characterization of permanent murine hybridomas secreting monoclonal anti‑thy‑1 antibodies. J Immunogenet. 1980 Dec; 7(6):455‑74. < PMID: 6787139 > | Zikan J, Draber P, Vojtiskova M: Monoclonal IgG3 (kappa) antibodies against murine Thy‑1.2 antigen produced by murine hybridomas: Differences in the specificity of the antigen binding site and in the structure of the hinge region. Folia Biol (Praha). 1982; 28(6):377‑94. < PMID: 6186535 > | Draberova L, Draber P: Thy‑1 glycoprotein and src‑like protein‑tyrosine kinase p53/p56lyn are associated in large detergent‑resistant complexes in rat basophilic leukemiacells. Proc Natl Acad Sci USA. 1993 Apr 15; 90(8):3611‑5. < PMID: 7682713 > | Haeryfar SM, Hoskin DW: Thy‑1: more than a mouse pan‑T cell marker. J Immunol. 2004 Sep 15; 173(6):3581‑8. < PMID: 15356100 > | Rege TA, Hagood JS: Thy‑1 as a regulator of cell‑cell and cell‑matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 2006 Jun; 20(8):1045‑54. < PMID: 16770003 > | Heneberg P, Lebduska P, Draberova L, Korb J, Draber P: Topography of plasma membrane microdomains and its consequences for mast cell signaling. Eur J Immunol. 2006 Oct; 36(10):2795‑806. < PMID: 17013982 > | Rege TA, Hagood JS: Thy‑1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochim Biophys Acta. 2006 Oct; 1763(10):991‑9. < PMID: 16996153 > | Bradley JE, Ramirez G, Hagood JS: Roles and regulation of Thy‑1, a context‑dependent modulator of cell phenotype. Biofactors. 2009 May-Jun; 35(3):258‑65. < PMID: 19422052 >

TDS & SDS
Close menu

Technical Data Sheet

Safety Data Sheet